India's Carlyle-backed Sequent Scientific up on deal to buy Provet stake

Viyash Scientific

23/09/2020 05:47

** Carlyle Group-backed animal healthcare company's shares
 SEQU.NS  up as much as 5.9% at 151.90 rupees, biggest intraday
rise since Aug. 6
    ** Sequent Scientific to buy 40% stake in Provet through
Alivira Animal Health, its wholly-owned unit
    ** Including session's gains, SEQU has more than doubled
YTD, outperforming the ~1% drop in the broader NSE Nifty 50
index  .NSEI 

 (Reporting by Vibhuti Sharma)
 ((RM: vibhuti.sharma.thomsonreuters.com@reuters.net))